ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $426,222 | +283.3% | 159,038 | +327.7% | 0.00% | – |
Q4 2023 | $111,192 | +398.8% | 37,188 | +131.9% | 0.00% | – |
Q2 2023 | $22,294 | -99.7% | 16,039 | -99.7% | 0.00% | -100.0% |
Q1 2023 | $7,586,462 | -64.5% | 4,771,360 | +39.1% | 0.02% | -67.2% |
Q4 2022 | $21,363,523 | +300.7% | 3,429,137 | +331.0% | 0.06% | +262.5% |
Q3 2022 | $5,331,000 | +6914.5% | 795,671 | +6546.7% | 0.02% | – |
Q2 2022 | $76,000 | -98.0% | 11,971 | -88.0% | 0.00% | -100.0% |
Q3 2020 | $3,717,000 | +16.3% | 100,000 | +60.6% | 0.03% | -3.6% |
Q2 2020 | $3,196,000 | -67.5% | 62,282 | -80.0% | 0.03% | -76.1% |
Q1 2020 | $9,830,000 | -56.1% | 311,738 | -17.0% | 0.12% | -12.0% |
Q4 2019 | $22,384,000 | +351.5% | 375,377 | +177.6% | 0.13% | +291.2% |
Q3 2019 | $4,958,000 | -34.0% | 135,230 | -16.2% | 0.03% | -29.2% |
Q2 2019 | $7,511,000 | +51.2% | 161,448 | +49.5% | 0.05% | +33.3% |
Q4 2018 | $4,968,000 | +1031.7% | 108,000 | +991.6% | 0.04% | +1700.0% |
Q3 2018 | $439,000 | -72.8% | 9,894 | -76.0% | 0.00% | -71.4% |
Q2 2018 | $1,616,000 | -85.1% | 41,224 | -72.6% | 0.01% | -84.4% |
Q1 2018 | $10,881,000 | -59.0% | 150,441 | -62.7% | 0.04% | -45.8% |
Q4 2017 | $26,544,000 | +34.7% | 403,164 | +2.5% | 0.08% | +7.8% |
Q3 2017 | $19,705,000 | +25.1% | 393,150 | +15.5% | 0.08% | +18.5% |
Q2 2017 | $15,757,000 | +801.4% | 340,483 | +587.8% | 0.06% | +712.5% |
Q1 2017 | $1,748,000 | – | 49,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
RA Capital Management | 704,701 | $24,883,000 | 3.05% |
Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
FT Options LLC | 22,834 | $806,000 | 1.06% |